Structures by: Hosamani K. M.
Total: 7
C18H16N4O5
C18H16N4O5
Heliyon (2019) 5, e01131
a=8.0803(2)Å b=13.8722(4)Å c=14.7217(4)Å
α=90° β=95.773(2)° γ=90°
4-[(4,5-dihydro-1,3-thiazol-2-ylthio)methyl] -6-methyl-2<i>H</i>-chromen-2-one
C14H13NO2S2
RSC Adv. (2015) 5, 79 64566
a=7.93370(10)Å b=8.09230(10)Å c=10.7299(2)Å
α=99.1900(10)° β=92.5250(10)° γ=96.4970(10)°
6-chloro-4-[(4,5-dihydro-1,3-thiazol-2- ylthio)methyl]-2<i>H</i>-chromen-2-one
C13H10ClNO2S2
RSC Adv. (2015) 5, 79 64566
a=7.3443(3)Å b=7.7814(3)Å c=12.6804(4)Å
α=85.486(2)° β=82.226(2)° γ=65.984(2)°
4-((4,5-dihydrothiazol-2-ylthio)methyl)-7- methyl-2<i>H</i>-chromen-2-one
C14H13NO2S2
RSC Adv. (2015) 5, 79 64566
a=7.8774(2)Å b=8.4986(3)Å c=11.2330(3)Å
α=91.435(2)° β=107.376(2)° γ=107.927(2)°
4-((4,5-dihydrothiazol-2-ylthio)methyl)-5,7-dimethyl- 2<i>H</i>-chromen-2-one
C15H15NO2S2
RSC Adv. (2015) 5, 79 64566
a=7.2356(8)Å b=7.9426(10)Å c=25.027(3)Å
α=90° β=96.742(8)° γ=90°
3-(2-(4-fluorobenzyl)-6-p-tolylpyrimidin-4-yl)-2H-chromen-2-one
C27H19FN2O2
RSC Adv. (2015) 5, 15 11261
a=8.0072(3)Å b=10.1043(4)Å c=13.2110(5)Å
α=100.264(2)° β=90.006(2)° γ=93.327(3)°
3-(2-(4-fluorobenzyl)-6-(4-methoxyphenyl)pyrimidin-4-yl)-2H-chromen-2-one
C27H19FN2O3
RSC Adv. (2015) 5, 15 11261
a=8.1330(2)Å b=10.2945(2)Å c=12.7544(3)Å
α=101.1920(10)° β=90.3440(10)° γ=95.4990(10)°